Trials / Terminated
TerminatedNCT00404300
Optivate in People With Von Willebrand Disease Undergoing Surgery
An Open Multi-centre Study to Investigate the Safety and Efficacy of OPTIVATE®, a High Purity, Dual Inactivated Factor VIII and Von Willebrand Factor Concentrate, in Patients With Von Willebrand Disease Who Are Undergoing Surgery
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Bio Products Laboratory · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
An open, multi-centre study in patients with von Willebrand Disease (VWD) undergoing surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Optivate | Plasma-derived Factor VIII |
Timeline
- Start date
- 2007-02-01
- Completion
- 2008-09-01
- First posted
- 2006-11-28
- Last updated
- 2010-03-03
Locations
4 sites across 2 countries: Israel, United Kingdom
Source: ClinicalTrials.gov record NCT00404300. Inclusion in this directory is not an endorsement.